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Background/Objectives—Telomere shortening is associated with age and risk of medical co-
morbidity. We assessed the relationship between measures of adiposity, leukocyte telomere length, 
and mortality and whether it is modified by age.
Subjects/Methods—Subjects with dual energy x-ray absorptiometry (DEXA) measures were 
identified using the National Health and Nutrition Examination Survey 1999–2002. Obesity was 
categorized using two body fat definitions (BF1%: men≥25%; females ≥35%; BF2% ≥28% and 
≥38%, respectively), body mass index (BMI), and waist circumference (WC) (men≥102cm; 
females≥88cm). Telomere length relative to standard reference DNA (T/S ratio) was assessed 
using quantitative polymerase chain reaction. Weighted multivariable regression models evaluated 
the association of telomere length with adiposity, both continuously and categorically (low/normal 
BF%, low/high WC and standard BMI categories). Differences in telomere length by age and 
adiposity were ascertained and subsequent models were stratified by age. Proportional hazard 
models assessed the risk of mortality by adiposity status. A telomere by adiposity interaction was 
tested in the entire cohort and by age category (<60 vs. ≥60 years; <70 vs. ≥70 years).
Results—We identified 7,827 subjects. Mean age was 46.1 years. Overall telomere length was 
1.05±0.01 (SE) that differed by BF1% (low/high:1.12±0.02 vs. 1.03±0.02;p<0.001), BF2% 
(1.02±0.02 vs. 1.11±0.02;p<0.001), BMI (underweight 1.08±0.03; normal 1.09±0.02; overweight 
1.04±0.02; obese 1.03±0.02;p<0.001), and WC (low/high 1.09±0.02 vs. 1.02±0.02;p<0.001). 
Adjusted β-coefficients evaluating the relationship between telomere length and adiposity 
(measured continuously) were: BF1% (β=−0.0033 ±0.0008;p<0.001), BF2% 
(−0.041±0.008;p<0.001), BMI (β=−0.025±0.0008;p=0.005), and WC (β=
−0.0011±0.0004;p=0.007). High BF% (BF1%: β=−0.035±0.011;p=0.002; BF2%: β=
−0.041±0.008; p<0.001) and WC (β=−0.035±0.011;p=0.008) were inversely related to TL. 
Stratifying by age, high BF1% (−0.061±0.013), BF2% (−0.065±0.01), BMI-obesity (−0.07±0.015) 
and high WC (−0.048±0.013) were significant (all p<0.001). This association diminished with 
increasing age. In older participants, TL was inversely related to mortality (HR 0.36 [0.27,0.49], as 
were those classified by BF1% (0.68 [0.56,0.81]), BF2% (0.75 [0.65,0.80], BMI (0.50 
[0.42,0.60]), and WC (0.72 [0.63,0.83]. No interaction was observed between adiposity status, 
telomere length and mortality.
Conclusions—Obesity is associated with shorter telomere length in young participants, a 
relationship that diminishes with increasing age. It does not moderate the relationship with 
mortality.
Keywords
telomere; obesity; epidemiology; aging
INTRODUCTION
Excess adiposity is associated with an increased risk of medical co-morbidity1, frailty2, 
institutionalization3 and premature death4. One potential mechanism that explains these 
relationships is a pro-inflammatory state that is observed in both the aging process and in the 
presence of adiposity5, 6. It has been hypothesized that the synergistic interplay between 
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aging and adiposity leads to biological and phenotypic impairments such as inflammatory 
burden and disability, respectively, in this population of older individuals with obesity.
Obesity-associated adipokines and pro-inflammatory cytokines, including IL-6 and TNF-α, 
are believed to directly lead to oxidative damage to DNA5, 6. Telomere segments are non-
transcriptional segments of DNA that protect chromosomes from degradation. Yet, telomeres 
themselves are not invulnerable to such damage, leading to their shortening which is known 
to be inversely related to longevity and the aging process. Shorter telomeres are associated 
with an increased risk of developing heart failure7, osteoporosis8 and dementia9, and 
interventions targeting the management of these underlying disease states have the potential 
to halt shortening and increase survival.
Both body mass index (BMI) and shorter telomere lengths have also independently observed 
to be related to mortality10, 11. Recently, two meta-analyses demonstrated a weak to 
moderate inverse correlation between telomere length and BMI12, 13. However, in certain 
populations (e.g. congestive heart failure, hemodialysis, nursing home residents) a mortality 
benefit is observed with higher BMI, a phenomenon termed ‘obesity paradox14. Whether an 
obesity paradox is observed in older adults with different telomere status is unknown. Such 
information could provide important information as a biomarker in individuals with obesity 
that could predict long-term mortality. We hypothesized that telomere length was inversely 
associated with body-fat defined adiposity, and determined whether it impacted mortality in 
a large-scale cohort of US adults.
METHODS
Study Design & Population
For this secondary analysis of data, we utilized the 1999–2002 National Health and 
Nutrition Examination Surveys (NHANES). This cross-sectional survey has been conducted 
and managed by the Centers for Disease Control since 1971. The survey contents and 
procedure manuals are available for online access at http://www.cdc.gov/nchs/nhanes.htm 
(accessed July 2016). The survey oversamples specific groups (race/ethnic minorities and 
older adults) and uses a multistage, complex, stratified probability sampling design making 
it representative of the non-institutionalized adult population of the United States. This study 
was exempt from Institutional Review Board review due to the de-identified nature of the 
data being analyzed.
Subjects were screened, interviewed, and ultimately examined in a mobile examination 
center by a licensed physician and staff (n=22,133). Persons aged <18 years (n=6,262) were 
excluded, in addition to individuals without body composition measures (see below) or 
telomere data (n=8,044). Our final analytical cohort consisted of 7,827 adults.
Measures of Obesity
Obesity was classified using three methods as the diagnostic accuracy of standard 
anthropometric measurements differ than gold standard methodologies: body mass index 
(BMI), waist circumference (WC) and body fat percentage. BMI was calculated as weight 
(in kilograms) divided by height (in meters) squared. Weight was measured using a 
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calibrated electronic digital scale, and height was measured after deep inhalation using a 
stadiometer. Subjects were classified using standard BMI categories (underweight 
≤18.5kg/m2; normal 18.5–24.9kg/m2; overweight 25.0–29.9kg/m2; obesity ≥30kg/m2). 
Waist circumference was measured in centimeters by trained staff measured standing using a 
tape measure around the trunk, at the iliac crest, crossing at the mid-axillary line. 
Measurements were all taken on the right side of the body unless amputations, casts or other 
factors prevented this from occurring. All body composition measures were assessed using 
dual-energy x-ray absorptiometry (Hologic Scanner, QDR-4500, Bedford, MA), a procedure 
lasting 3 minutes. Exclusion criteria consisted of height≥192.5cm, weight ≥136.4kg, or any 
individual with a procedural contraindication. All metal objects were removed (except false 
teeth or hearing aids). High percent body fat was categorized using sex-specific cutpoints 
used in our previous studies (males≥25%; females≥35%)15, 16, but also using ≥28% in men, 
and ≥38% in females.
Telomere Data
Blood samples were collected by standard protocol. The telomere length assay was 
performed using polymerase chain reaction at the University of California, San Francisco. 
Telomere length relative to standard reference DNA (T/S) ratio was measured, with each 
sample assayed 3 times on 3 different days, on duplicate wells (6 data points). Full details 
are available at http://cdc.gov/nchs/nhanes under the laboratory section. The interassay 
coefficient of variation was 6.5%. Values represent the mean (standard deviation) of the T/S 
ratio.
Co-variates
A self-reported questionnaire assessed race, smoking status (current, former, never) and co-
morbid conditions (Have you ever been told by a doctor that you had [medical problem]?). 
Subjects completed all answers or if they were unable to, their caregiver completed the 
questions in either English or in Spanish. Age was self-reported from the initial screening 
questionnaire, and subsequently verified against an age verification chart, with differences 
reconciled using a standard protocol. Age was also categorized as performed in previous 
analyses and as outlined by the NHANES sampling domains (https://www.cdc.gov/nchs/
data/series/sr_02/sr02_160.pdf) (18–60, 60–69.9, 70–79.9 and ≥80 years). Physical activity 
was categorized in four levels (sits, walks, light loads, and heavy work) using a self-reported 
questionnaire that asked participants “Please tell me which of these four sentences best 
describes your usual daily activities (sits: sits during the day and does not walk about very 
much; walks – stand or walk about a lot during the day but does not have to carry or lift 
things very often; light loads – lifts a light load or has to climb stairs or hills often; heavy 
work – does heavy work or carries heavy loads.
Mortality Data
Mortality data was obtained from the National Death Index, linked to the NHANES data 
using a unique study identifier. The 2015 public use linked mortality file was current from 
time of the mobile examination center evaluation through December 31, 2011. Full details 
are available at https://www.cdc.gov/nchs/ndi/index.htm. Time to death was calculated in 
days from the examination date of death.
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Statistical Analyses
All data was merged into a single dataset according to NHANES protocols. Data was 
weighted and primary sampling unit and stratum were accounted for in the analysis. 
Continuous variables are presented as means ± standard errors, and categorical variables as 
counts (percent). A t-test and chi-square compared continuous and categorical variables. For 
multi-level variables, an ANOVA was performed. Age was stratified by age ≥60 and <60 
years, and by <70 and ≥70 years to reflect the changes observed in body composition 
observed with the aging process17–19. Elevated body fat was categorized by sex (BF1%: 
males≥25%; females ≥35%; BF2%: males≥28%; females ≥38%) as was waist circumference 
(males≥102cm; females ≥88cm). Unpaired t-tests compared telomere length between young 
and older individuals (age <60 vs. ≥60; and age <70 vs. ≥70 years) and as an exploratory 
analysis among age categories (age 60–69.9, 70–79.9, and ≥80years) for high/low adiposity 
measure (body fat, BMI, WC). Overall mortality rates were also assessed.
Our primary outcome was to ascertain the association between each body composition 
measure (predictor) and telomere length (outcome). Separate models were created for each 
body fat definition (referent=low), BMI (referent=normal); WC (referent=low). Each 
adiposity measure was also assessed as a continuous variable. B-coefficients ± standard 
errors with associated p-values are presented. Model was 1 was unadjusted; Model 2 was 
adjusted for age, race, education, smoking; Model 3 was further adjusted for diabetes 
mellitus, congestive heart failure, non-skin cancer, coronary artery disease, arthritis, physical 
activity, and smoking status. Interactions between age category (cutpoint of 60 or 70 years) 
and each adiposity measure (BF1%, BF2%, BMI or WC) were assessed. We created cox 
proportional hazard models to separately assess the risk of death by adiposity measure, TL 
and death. A separate model assessed telomere length and mortality with a telomere * 
adiposity category interaction term. We also stratified by age with a similar interaction term. 
As an ancillary analysis, separate interaction terms for age category * telomere length was 
assessed within each adiposity category (high vs. low). All analyses were performed using 
STATA v.13 (College Station, TX). A p-value <0.05 was considered statistically significant.
RESULTS
We identified 7,827 individuals who met our inclusion criteria that were part of the 
analytical cohort. Baseline characteristics are represented in Table 1. Mean age was 
46.1±0.37 years (51.4 % female). Differences were observed in race, comorbidity, smoking 
status, physical activity level and body fat and waist circumference. Telomere length was 
1.05±0.01 in the overall cohort but was shorter in the older compared to the younger cohorts 
(<60 years: 0.91±0.02 vs. 1.10±0.01;p<0.001; age 70 years: 0.87±0.02 vs. 
1.08±0.01;p<0.001). Telomere length was higher in younger participants independent of 
body fat status. In older adults, telomere length shortened between ages 60–69.9, 70–79.9 
and ≥80 years in the overall cohort (0.96±0.02, 0.88±0.02, and 0.84±0.02; p<0.001). This 
decrease in telomere length with age was also observed across BF and WC categories (Table 
2).
We observed consistent relationships with additional covariate adjustment (Table 3). High 
BF1% or BF2% and WC were strongly associated with lower telomere length (β=
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−0.035±0.011, p=0.002, β=−0.041±0.008, p<0.001 and β=−0.032±0.011, p=0.008). Testing 
the interactive effect between body fat, BMI, and waist circumference as continuous 
variables with age on telomere length demonstrated p-values of <0.001, <0.001 and 0.007, 
respectively. High BF, BMI-obesity and high WC were all inversely associated with 
telomere length (Table 4), a trend that dissipated with increasing age. The analysis was 
subsequently stratified by age and suggested that adiposity is associated with reduced 
telomere length but disappears with increasing age. This is most clear with BF% and less 
clear for BMI and WC. Multivariable mortality analyses of age category, telomere length 
and mortality are noted in Table 5. High BF, BMI and WC were protective in older adults 
but led to a higher mortality risk in younger adults. TL was inversely associated with 
mortality risk in older adults. We did not observe an interaction between adiposity category, 
telomere length and mortality. This was also not observed between high/low age categories. 
Our ancillary analyses (Appendix 2 and 3) demonstrate that in low adiposity categories there 
is an interaction between telomere length and age on mortality.
DISCUSSION
With an increased interest in the contribution of telomere length in the aging process, this 
study suggests an inverse association between shorter telomere length and increased 
adiposity. However, our mortality results suggest that with increasing age, there is an 
attenuation in the association of adiposity on TL and mortality. The results also imply that 
among the very old, for those with obesity, irrespective of how it is defined, telomere length 
compared to individuals with normal body composition may not have a significant impact on 
important outcomes.
We observed a consistent inverse relationship between high body fat and WC on length of 
telomeres in the entire adult population examined. Our results may provide biological 
insight to the associations of both body fat and WC with disability and mortality in large, 
population-based studies20, 21. When our analyses were stratified by age, the association 
between adiposity and telomere length was only observed in younger adults and diminished 
in older adults. A few potential explanations could exist. First, age-associated body 
composition changes (fat and muscle) between the ages and 60–70 may impact peripheral 
blood telomere length, and could provide some potential mechanistic explanation to our 
findings. Whether and how adipose tissue modifies the effect of telomere repair 
mechanisms, for example reduced expression of telomerase22, 23, is unclear but could play a 
role. Our results may parallel the findings, in part, to those of Bischoff et al who found that 
with increasing age, the relationship between telomere length and age lessened24, yet 
contrasts to the findings by Lee25. Only with longitudinal data could the relationship 
between adiposity and telomere length be confirmed. As such, our findings should be 
considered exploratory.
The cross-sectional associations and mortality estimates became non-significant in older 
adults, a phenomenon that has been observed with the obesity paradox in certain 
populations14, where obesity can be ‘protective’ on longer term outcomes in older adults. By 
deliberately stratifying by age, we assessed the relationship of telomere length with aging. 
Telomere length in younger individuals with obesity is lower, suggesting a higher-risk 
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population. Yet, this relationship appears to be non-significant across all older age groups. 
We evaluated the interaction of adiposity on telomere length on mortality and found that it 
did not modify its risk. In older adults with adiposity, there appeared to be a protective effect 
of adiposity on death, results which were non-significant after incorporating telomere length 
in the analysis. Those with adiposity may have died earlier and those remaining in older age 
may have had a slower rate of accumulation of subcutaneous and visceral adiposity, both of 
which can have a negative impact on telomere length. Previous studies have demonstrated 
that duration of adiposity is a negative prognostic factor in health outcomes26. In certain 
individuals, this shorter timeframe prevents the accumulation of inflammatory and co-
morbid factors that could contribute to disease. Factors such as fat-free mass, nutritional 
status or cardiorespiratory fitness may also play a role.
These findings can add to the growing and disparate literature of how obesity can potentially 
moderate telomere length through inflammatory and oxidative stress mechanisms. A 
possible hypothesis to explain the lack of association between adiposity and TL on mortality 
in the oldest old, is that accumulated exposures from obesity (e.g. cardiometabolic, 
musculoskeletal or organ-speciifc harms) could plateau and not result in additional 
problems. Senescence could be prematurely triggered by obesity27–29. In vitro studies have 
demonstrated that weight changes may be implicated in this process as well. Adipose tissue 
changes with age which may reflect underlying genetic changes, and hence telomere 
alterations. Future work should focus on understanding more thoroughly these mechanistic 
changes as it has implications on other telomere-related diseases of aging.
The multivariable modeling deliberately adjusted for a number of sociodemographic and 
comorbidities that could impact both obesity and telomere lengthening. After model 
adjustment, the strength of association did not markedly change. These findings implicate 
high adiposity and possible adipokines could be the main toxic exposure impacting telomere 
length. We would have expected that the relationship would weaken our estimates after 
adding covariates representing inflammatory mediators yet the dataset did not have such 
information. Other pro-inflammatory and/or lipid-mediating hormones that were 
unmeasured likely influence this relationship30. The relationship between adipose-associated 
factors such as the adipokines leptin and adiponectin with telomere length or telomerase 
activity is not entirely clear. Similar positive associations were observed between telomere 
length and insulin-like growth factor in a study of elderly men31. Another cross sectional 
study found no significant association between telomere activity and adiposity, BMI, 
visceral fat, adiponectin or leptin in a smaller cohort of healthy adults (n=317, age 40–64) 
recruited from a health center30. The one prospective study that has reported telomere length 
change over time among individuals with stable coronary disease, demonstrated 3 
trajectories of individuals whose leukocyte telomere length shortened, lengthened or 
remained stable32. Abdominal obesity (WHR) was independently predictive of increased 
risk of shorter telomeres over a 5 year follow-up, along with the other independent 
predictors, baseline telomere length, age and male sex, even when controlling for BMI, 
adipokines (adiponectin, leptin) and inflammatory markers (CRP, IL-6 and TNFa). Thus 
specific strata such as sex or age, as demonstrated in the current study, may influence 
associations and explain discrepant findings when analyses do not account for these 
moderators.
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The results from a recent systematic review and meta-analysis demonstrated that the 
association between telomere length and BMI was weak to moderate in nature12, 13. Our 
study indicated that the standard BMI categories were not related to telomere length and did 
not impact risk of death. A potential explanation could be that BMI is known to be a poor 
marker of general adiposity, missing 50% of those with obesity in a general population33 but 
also having a poor sensitivity in an older population34. This ubiquitous measure incorporates 
both fat and muscle mass, while DEXA-measured body fat ascertains overall fat mass, and 
waist circumference is a surrogate for central adiposity. Our results may explain the 
inconsistent results observed with relationships between adiposity and telomere length, 
when using BMI as a surrogate for adiposity, as described by An et al35 and Njajou et al36.
A disadvantage of categorizing a continuous variable into categories is not only the loss of 
study power, but values slightly above the threshold may have only incremental and modest 
long-term risk, potentially resulting in overdiagnosis37. Misclassification is possible as well, 
and this has implications for public health in the identification and management of higher 
risk populations. We deliberately used each of these anthropometric measures in our 
modeling as a continuous variable to circumvent this issue and to demonstrate that our 
results were consistent.
The study has a number of limitations inherent to NHANES such as the use of community-
dwelling adults and self-reported bias. As older adulthood generally is considered 65 years 
and older, we deliberately created two dichotomous cutpoints to assess changes in these age 
groups; however, we recognize that our sample size in those aged ≥70 years may limit our 
ability to make generalizations. Other biomarkers, including inflammatory cytokines could 
be helpful to explain this phenomenon between increased adiposity and decreased telomere 
length and their interplay should be considered in further studies. Lifespan changes of 
adiposity are not accounted for in this analysis including weight change and weight cycling. 
Importantly, alterations in physical function that could impact morbidity, mortality and 
quality of life should be considered.
Implications
In an era of individualized medicine, our results provide some helpful guidance for clinical 
practice. First, using telomere length to predict outcomes on disease states in populations 
with obesity may only reveal associations in younger as compared to older adults. Second, 
the use of biological data in obesity medicine, while still in its infancy, may explain a 
number of the relationships that are observed in large-scale epidemiological studies. This 
translational approach can help clarify relationships that are inconclusive. Third, our results 
further suggest the need to move away from traditional measures of adiposity (ie: BMI) and 
move towards body fat percent, which has increased ability to predict long-term outcomes. 
In low-tech settings, at least waist circumference or WHR should be considered. Fourth, our 
results provide evidence for an independent effect of obesity on telomere length specifically 
in younger adults. Yet, we did not observe any interactive effects, specifically in older adults. 
Engaging in healthy lifestyle measures improves one’s chances of preventing disability38, 
enhancing quality of life, and reducing disease burden, all important tenants in old age. Yet, 
our results prompt the need for further evaluation of longitudinal datasets with repeated 
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measures to assess whether reduced adiposity in earlier geriatric years can restore 
telomerase activity, and thus telomere length. This reversal may be beneficial in this 
population.
CONCLUSIONS
Shorter telomere length is inversely related to higher percent body fat and waist 
circumference but becomes non-significant in adults over the age of 60 years. Adiposity 
does not appear to modify the relationship between telomere length and mortality in 
community-dwelling adults.
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Table 1
Baseline Characteristics of Subjects NHANES 1999–2002 Cohort
Age Cohort
Overall <60 years ≥60 years p-value
N=7,827 N=5,155 N=2,672
Age, years ± s.e. 46.1±0.37 38.9±0.26 70.9±0.28 <0.001
Female sex (%) 4,056 (51.4) 2,744 (50.2) 1,312 (55.5) <0.001
Weight, kg 80.3±0.39 81.1±0.46 77.5±0.40 <0.001
Race <0.001
 Hispanic American 2,293 (13.8) 1,629 (15.5) 664 (7.8)
 Non-Hispanic White 3,965 (72.9) 2,408 (70.1) 1,557 (82.7)
 Non-Hispanic Black 1,333 (9.3) 936 (10.0) 397 (6.9)
 Other 236 (4.0) 182 (4.4) 54 (2.7)
Co-Morbid Conditions
 Hypertension 1,922 (82.7) 730 (78.2) 1,192 (88.5) <0.001
 Diabetes Mellitus 840 (7.7) 303 (5.1) 537 (16.9) <0.001
 Congestive Heart Failure 230 (2.2) 55 (1.1) 175 (6.2) <0.001
 Non-skin cancer 644 (7.8) 173 (4.1) 471 (20.6) <0.001
 Stroke 237(2.3) 51 (0.99) 186 (6.7) <0.001
 COPD 542 (7.7) 290 (6.5) 252 (11.6) <0.001
 Osteoporosis 96 (0.85) 36 (0.51) 60 (2.0) <0.001
 Kidney Disease 108 (2.4) 47 (1.9) 61 (4.0) 0.002
 Coronary Artery Disease 578 (6.1) 134 (2.7) 444 (18.0) <0.001
 Arthritis 1,895 (21.6) 654 (13.5) 1,241 (49.2) <0.001
Current Smoker <0.001
 Current 1,695 (24.4) 1,369 (28.0) 326 (12.2)
 Never 4,016 (50.1) 2,763 (50.9) 1,253 (47.0)
 Former 2,101 (25.5) 1,014 (21.1) 1,087 (40.8)
Physical Activity Level <0.001
 Sits 1,964 (24.6) 1,184 (23.7) 780 (27.8)
 Walks 4,137 (50.3) 2,616 (48.6) 1,521 (56.4)
 Light Loads 1,212 (17.7) 912 (18.9) 300 (13.8)
 Heavy Work 505 (7.3) 442 (8.9) 63 (2.1)
Anthropometric Measures
 % Body Fat 33.9±0.15 33.0±0.16 36.9±0.15 <0.001
 BMI, kg/m2 28.1±0.14 28.1±0.16 28.2±0.14 0.30
 WC, cm 96.0±0.35 95.0±0.39 99.6±0.29 <0.001
Body Mass Index Categories
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Age Cohort
Overall <60 years ≥60 years p-value
N=7,827 N=5,155 N=2,672
 Underweight 111 (1.8) 79 (1.8) 32 (1.5)
 Normal 2,291 (32.9) 1,605 (34.2) 686 (32.4)
 Overweight 2,756 (35.0) 1,757 (34.1) 999 (31.9) 0.003
 Obesity 2,420 (30.4) 1,624 (29.9) 796 (27.7)
Data are mean ± standard errors or counts (%). Data are weighted according to the National Health and Nutrition Examination Survey protocol
Abbreviations: BMI – body mass index; COPD – chronic obstructive pulmonary disease; WC – waist circumference
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